Ubenimex (INN) also known as bestatin is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B leukotriene A4 hydrolase and aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
This page contains content from the copyrighted Wikipedia article "Ubenimex"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.